Medicare Enrolled

Dr. Jose Esquilin, M.D.

Pediatric Hematology & Oncology Physician · Corpus Christi, TX
Speaking/Promotional
3533 S ALAMEDA ST, Corpus Christi, TX 78411
3616945311
In practice since 2007 (18 years)
NPI: 1417131350 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Esquilin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Esquilin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Esquilin

Dr. Jose Esquilin is a pediatric hematology & oncology physician in Corpus Christi, TX, with 18 years in practice.

Between the years covered by Open Payments, Dr. Esquilin received a total of $23,638 from 49 pharmaceutical and/or device companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric hematology & oncology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Esquilin is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $23,638 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$23,638
Total received (2018-2024)
Avg $3,377/year across 7 years
Top 12% in TX for pediatric hematology & oncology physician
49
Companies
194
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,560 (65.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,078 (34.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,248
2023
$1,173
2022
$3,596
2021
$5,915
2020
$8,044
2019
$1,350
2018
$1,313

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Global Blood Therapeutics, Inc.
$15,366
JAZZ PHARMACEUTICALS INC.
$1,685
Novartis Pharmaceuticals Corporation
$680
Fennec Pharmaceuticals, Inc.
$676
Alexion Pharmaceuticals, Inc.
$613
Jazz Pharmaceuticals Inc.
$495
Servier Pharmaceuticals LLC
$382
Sobi, Inc
$382
SOBI, INC
$283
PFIZER INC.
$265
BIOVERATIV THERAPEUTICS INC.
$232
AstraZeneca Pharmaceuticals LP
$222
BTG International, Inc.
$217
SANOFI-AVENTIS U.S. LLC
$184
Y-mAbs Therapeutics, Inc.
$167
Novo Nordisk Inc
$137
SERVIER PHARMACEUTICALS LLC
$128
Adaptive Biotechnologies Corporation
$128
Agios Pharmaceuticals, Inc.
$126
Horizon Therapeutics plc
$125
RARE DISEASE THERAPEUTICS, INC.
$115
United Therapeutics Corporation
$93
QOL Medical, LLC
$88
Pharming Healthcare, Inc.
$86
Teva Pharmaceuticals USA, Inc.
$83
Takeda Pharmaceuticals U.S.A., Inc.
$76
Nestle HealthCare Nutrition Inc.
$49
Medtronic USA, Inc.
$40
Cumberland Pharmaceuticals, Inc.
$39
AbbVie Inc.
$39
Retrophin, Inc.
$38
Mirum Pharmaceuticals, Inc.
$37
AbbVie, Inc.
$35
Silvergate Pharmaceuticals, Inc.
$33
ALCRESTA THERAPEUTICS, INC.
$32
Bayer Healthcare Pharmaceuticals Inc.
$29
Emmaus Medical, Inc.
$26
Duchesnay USA Incorporated
$24
Day One Biopharmaceuticals
$22
Alcresta Therapeutics, Inc.
$21
ABBVIE INC.
$17
Genentech USA, Inc.
$17
APO-PHARMA USA, INC.
$17
Sandoz Inc.
$17
USWM, LLC
$16
Amgen Inc.
$16
GENZYME CORPORATION
$14
Shire North American Group Inc
$14
Horizon Pharma plc
$12
Top 3 companies account for 75.0% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTIMMUNE · ADVATE · AFINITOR · ALPROLIX · CABLIVI · CREON · Creon · DANYELZA · DEFERIPRONE · DEFITELIO · Defitelio · EUCRISA · Endari · Erwinaze · Esperoct · FASENRA · Fabhalta · GAMIFANT · GATTEX · Gamifant · HEMLIBRA · HYRIMOZ · IWILFIN · JADENU · KRISTALOSE · KYMRIAH · Kanuma · Kristalose · Livmarli · NO PRODUCT DISCUSSED · NovoSeven · Nplate · OJEMDA · ONCASPAR · ORENITRAM · OXBRYTA · PROMACTA · PYRUKYND · Pedmark · Purixan · QVAR · RELIZORB · REZUROCK · RUCONEST · RYLAZE · SARCLISA · SOLIRIS · STRATA · SUCRAID · Siklos · Soliris · Sucraid · ULTOMIRIS · VORAXAZE · VPRIV · VYXEOS · Vitrakvi · XYNTHA · Xatmep · ZENPEP · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pediatric hematology & oncology physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for a pediatric hematology & oncology physician in Corpus Christi?
Compare pediatric hematology & oncology physicians in the Corpus Christi area by procedure volume, costs, and industry payment transparency.
Browse pediatric hematology & oncology physicians nearby

Geographic Context

Pediatric Hematology & Oncology Physicians within 10 mi
5
Per 100K population
1.4
County median income
$66,021
Nearest hospital
CORPUS CHRISTI MEDICAL CENTER,THE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Esquilin is a pediatric hematology & oncology physician, and high industry engagement (speaking/promotional, top 12%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Esquilin receive payments from pharmaceutical companies?
Yes. Dr. Esquilin received a total of $23,638 from 49 companies across 194 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Esquilin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →